Turn evidence-backed innovation into credible, fundable and market-ready products.
EQUIS Strategy helps science-driven product teams clarify their scientific evidence, claims, EU funding strategy and market positioning, so applied science-based products can move confidently from research toward launch, growth or partnerships.
Scientific evidence and claims turned into commercial leverage.
Roadmaps that align EU funding, dilutive and strategic capital.
Positioning sharp enough to carry a product to market.
EQUIS Strategy is proud to be supported through the Erasmus for Young Entrepreneurs programme, an initiative co-funded by the European Union, fostering entrepreneurship, international collaboration and business development across Europe.


Three engagements, built around evidence.
Funding strategy, go-to-market preparation and claims and evidence advisory for applied science-based products.
Funding & Project Roadmap
Align science, product and EU funding into a credible 12–36 month plan that investors and grant bodies can underwrite.
Market Preparation & Launch
Positioning, value proposition and go-to-market preparation that make a science-driven product ready to sell.
Claims, Evidence & Regulatory-Aware Advisory
Turn study data into defensible scientific claims and a regulatory-aware pathway that protects your brand and your launch.
Priority sectors.
We focus where evidence, regulation and consumer trust converge, and where good science deserves a credible commercial story.
Explore sectors
A grounded, applied process.
Read the evidence, the product, the market and the funding landscape.
Sharpen positioning, claims architecture and the strategic question.
Build the roadmap: funding, milestones, regulatory and commercial.
Translate strategy into decks, narratives and engagement-ready assets.
Insights
A monthly read on evidence, claims, funding signals and category moves shaping consumer innovation. Sharp, applied, and built for product and innovation leaders.
Have a product worth funding?
Tell us where you are. We'll tell you what it would take to make it credible, fundable and market-ready.
